Instrument Inactif

Autres langues Proteo, Inc. Other OTC

Actions

PTEO

US74369R3084

Recherche biotechnologique et médicale

Autres langues

01/03/23	U.S. Special Forces launch counter-terrorism drills with African armies
20/07/20	PROTEO INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
10/07/20	PROTEO INC : Submission of Matters to a Vote of Security Holders (form 8-K)
05/06/20	Proteo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
05/06/20	PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
12/05/20	PROTEO INC : Other Events (form 8-K)
07/05/20	Proteo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
07/05/20	PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
30/03/20	PROTEO INC : Other Events (form 8-K)
03/03/20	PROTEO INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
14/11/19	Proteo, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
05/08/19	Proteo, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
14/05/19	Proteo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019
15/04/19	Proteo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018
19/11/18	Proteo, Inc. Announces Management Changes
21/11/14	Proteo, Inc. and Proteo Biotech AG Announces Final Analysis of the Phase II Clinical Study on Elafin in Coronary Artery Bypass Surgery
08/11/13	Proteo Inc : Patient recruitment and treatment in Elafin CABG Phase II clinical trial completed
07/12/11	Proteo Incorporated : Proteo, Inc. / Proteo Biotech AG: Major advances in the elafin development program for lung diseases – NIH supports research on Elafin with a $10.8 million grant
16/08/11	PROTEO INC : Proteo, Inc. / Proteo Biotech AG: EMPIRE-Study recruits first coronary bypass patients
18/06/10	PROTEO INC : Proteo, Inc./ Proteo Biotech AG: Proteo's Elafin Will Be Tested at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
30/11/-1	PROTEO : Proteo, Inc./Proteo Biotech AG: Clinical Study in Harvard Reveals Elafin Deficiency in Acute Respiratory Distress Syndrome (ARDS)
30/11/-1	PROTEO : Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Approval for a Phase II Clinical Trial with Elafin in Kidney Transplantation
30/11/-1	PROTEO : Proteo, Inc./Proteo Biotech AG: Start of the Phase II clinical trial with Elafin